Nephros, Inc. Receives the 2009 Frost & Sullivan Medical Device Patient Care Company of the ...(afiltration ( HDF ) system is designed t...),Health

Date:1/14/2009

afiltration ("HDF") system is designed to improve the quality of life for the End-Stage Renal Disease (ESRD) patient while addressing the critical financial and clinical needs of the care provider. ESRD is a disease state characterized by the irreversible loss of kidney function. The Nephros HDF system removes a range of harmful substances more effectively, and with greater capacity, than existing ESRD treatment methods, particularly with respect to substances known collectively as "middle molecules." These molecules have been found to contribute to such conditions as dialysis-related amyloidosis, carpal tunnel syndrome, degenerative bone disease and, ultimately, mortality in the ESRD patient. Nephros ESRD products are sold and distributed throughout Europe and are currently being used in over fifty clinics in Europe. The Nephros Dual Stage Ultra-filter (DSU) is the basis for Nephros's line of water filtration products. The patented dual stage cold sterilization ultrafilter has the capability to filter out bacteria and, due to its exceptional filtration levels, filter out many viruses, parasites and biotoxins. Sale of the DSU has begun at several major U.S. medical centers for infection control and has been selected for further development by the U.S. Marine Corps for purification of drinking water by soldiers in the field. For more information on Nephros, please visit its website at http://www.nephros.com.

Forward-Looking Statements

Statements in this news release that are not historical facts constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "PSLRA"). Such statements may be preceded by words such as "may," "plans," "expects," "believes," "hopes," "potential" or similar words. For such statements, Nephros claims the protection of the PSLRA.

Forward-looking statements are not guarantees of future
'/>"/>

SOURCE Nephros, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Med-Emerg International Inc. receives court approval for AIM Health Group arrangement
2. St. Marys Health System in Maine Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service
3. Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
4. Dalcons Healthcare Communications Software Receives Internet Telephony Magazine Product of the Year Award
5. Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008
6. WellPoint Receives Seven eHealthcare Leadership Awards
7. Ziosoft Receives FDA Clearance for CT Brain Perfusion Application
8. Cell Therapeutics Receives $7.5 Million Under Joint Venture Agreement With Spectrum Pharmaceuticals
9. Guru Program Pioneered by Tom Gable Receives Official Registration from USPTO
10. Accuray Receives Prestigious Awards for 2008 Advertising Campaign
11. AGA Medical Receives Japanese Approval for AMPLATZER(R) Duct Occluder